| Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
|---|
| C548651 |
2-(1'H-indolo-3'-carbonyl)thiazole-4-carboxylic acid methyl ester |
2-(1'H-indolo-3'-carbonyl)thiazole-4-carboxylic acid methyl ester results in increased expression of SLC26A2 mRNA | increases expression | 19933214
|
| C016601 |
4-hydroxytamoxifen |
4-hydroxytamoxifen results in decreased expression of SLC26A2 mRNA | decreases expression | 16514628
|
| D000082 |
Acetaminophen |
Acetaminophen affects the expression of SLC26A2 mRNA | affects expression | 17562736
|
| D016604 |
Aflatoxin B1 |
Aflatoxin B1 affects the expression of SLC26A2 protein | affects expression | 20106945
|
| D000643 |
Ammonium Chloride |
Ammonium Chloride affects the expression of SLC26A2 mRNA | affects expression | 16483693
|
| D015123 |
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of SLC26A2 mRNA | decreases expression | 20018196
|
| D016572 |
Cyclosporine |
Cyclosporine results in increased expression of SLC26A2 mRNA | increases expression | 20106945
|
| D004958 |
Estradiol |
[Estradiol co-treated with Tetrachlorodibenzodioxin] results in decreased expression of SLC26A2 mRNA | affects cotreatment|decreases expression | 19619570
|
| D004958 |
Estradiol |
Estradiol results in decreased expression of SLC26A2 mRNA | decreases expression | 19619570
|
| D004958 |
Estradiol |
Estradiol results in increased expression of SLC26A2 mRNA | increases expression | 16514628
|
| D004958 |
Estradiol |
[Progesterone co-treated with Estradiol] results in increased expression of SLC26A2 mRNA | affects cotreatment|increases expression | 17404688
|
| D004997 |
Ethinyl Estradiol |
[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of SLC26A2 mRNA | affects cotreatment|increases expression | 17942748
|
| C070081 |
fulvestrant |
fulvestrant results in decreased expression of SLC26A2 mRNA | decreases expression | 16514628
|
| D008727 |
Methotrexate |
SLC26A2 protein affects the susceptibility to Methotrexate | affects response to substance | 16217747
|
| C006253 |
pirinixic acid |
[pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of SLC26A2 mRNA | affects binding|decreases expression|increases activity | 19710929
|
| C006253 |
pirinixic acid |
pirinixic acid results in increased expression of SLC26A2 mRNA | increases expression | 17426115
|
| D011374 |
Progesterone |
[Progesterone co-treated with Estradiol] results in increased expression of SLC26A2 mRNA | affects cotreatment|increases expression | 17404688
|
| D011374 |
Progesterone |
Progesterone results in increased expression of SLC26A2 mRNA | increases expression | 17404688
|
| D020849 |
Raloxifene |
Raloxifene results in decreased expression of SLC26A2 mRNA | decreases expression | 16514628
|
| D013749 |
Tetrachlorodibenzodioxin |
[Estradiol co-treated with Tetrachlorodibenzodioxin] results in decreased expression of SLC26A2 mRNA | affects cotreatment|decreases expression | 19619570
|
| D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin results in decreased expression of SLC26A2 mRNA | decreases expression | 19619570
|
| D013749 |
Tetrachlorodibenzodioxin |
[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of SLC26A2 mRNA | affects cotreatment|increases expression | 17942748
|
| D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin results in increased expression of SLC26A2 mRNA | increases expression | 19933214
|
| D014302 |
Trinitrobenzenesulfonic Acid |
Trinitrobenzenesulfonic Acid results in decreased expression of SLC26A2 mRNA | decreases expression | 17982090
|
| Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
|---|
| MESH:D000014 |
Abnormalities, Drug-Induced |
|
Methotrexate |
8.66 | 12039119 |
| MESH:D000014 |
Abnormalities, Drug-Induced |
|
Tetrachlorodibenzodioxin |
8.66 | 11752688 15322242 14514962 |
| MESH:C536016 |
Achondrogenesis type 1B |
marker/mechanism |
|
| |
| MESH:D000138 |
Acidosis |
|
Ammonium Chloride |
3.58 | 18287403 |
| MESH:D000152 |
Acne Vulgaris |
|
Ethinyl Estradiol |
3.97 | 17505938 |
| MESH:D055371 |
Acute Lung Injury |
|
pirinixic acid |
3.12 | 18653653 |
| MESH:D000230 |
Adenocarcinoma |
|
Estradiol |
4.22 | 11473722 |
| MESH:D000230 |
Adenocarcinoma |
|
Ethinyl Estradiol |
4.22 | 14692618 |
| MESH:D018248 |
Adenoma, Liver Cell |
|
pirinixic acid |
9.97 | 16434500 |
| MESH:D018248 |
Adenoma, Liver Cell |
|
Tetrachlorodibenzodioxin |
9.97 | 16835633 |
| MESH:D000419 |
Albuminuria |
|
Raloxifene |
4.60 | 17308373 17451421 |
| MESH:D000544 |
Alzheimer Disease |
|
Raloxifene |
2.54 | 15800139 |
| MESH:D000740 |
Anemia |
|
Tetrachlorodibenzodioxin |
2.95 | 11748828 |
| MESH:D000799 |
Angioedema |
|
Acetaminophen |
3.87 | 10982225 |
| MESH:D001161 |
Arteriosclerosis |
|
Ethinyl Estradiol |
3.48 | 11256880 |
| MESH:D001169 |
Arthritis, Experimental |
|
Ethinyl Estradiol |
2.66 | 15885639 |
| MESH:D001172 |
Arthritis, Rheumatoid |
|
Methotrexate |
3.10 | 17286800 |
| MESH:C535395 |
Atelosteogenesis type 2 |
marker/mechanism |
|
| |
| MESH:D001284 |
Atrophy |
|
fulvestrant |
4.86 | 11514358 |
| MESH:D001321 |
Autistic Disorder |
|
Acetaminophen |
1.42 | 18445737 |
| MESH:D001778 |
Blood Coagulation Disorders |
|
pirinixic acid |
8.78 | 19483382 |
| MESH:D001778 |
Blood Coagulation Disorders |
|
Tetrachlorodibenzodioxin |
8.78 | 12125929 |
| MESH:D001836 |
Body Weight Changes |
|
Tetrachlorodibenzodioxin |
3.82 | 15340226 |
| MESH:D001848 |
Bone Diseases, Developmental |
marker/mechanism |
|
| 18925670 |
| MESH:D001848 |
Bone Diseases, Developmental |
|
Tetrachlorodibenzodioxin |
2.76 | 15746008 |
| MESH:D020201 |
Brain Hemorrhage, Traumatic |
|
Progesterone |
5.37 | 17868700 |
| MESH:D001930 |
Brain Injuries |
|
Progesterone |
11.01 | 15665606 15845082 15380490 |
| MESH:D001930 |
Brain Injuries |
|
Raloxifene |
11.01 | 16580743 |
| MESH:D001943 |
Breast Neoplasms |
|
Estradiol |
2.97 | 17289903 17018787 17261762 16675129 14630087 19861407 12948864 18497071 |
| MESH:D001943 |
Breast Neoplasms |
|
fulvestrant |
2.97 | 18984771 |
| MESH:D001943 |
Breast Neoplasms |
|
Methotrexate |
2.97 | 16978400 |
| MESH:D001943 |
Breast Neoplasms |
|
Progesterone |
2.97 | 17614352 16175315 15562024 |
| MESH:D001943 |
Breast Neoplasms |
|
Raloxifene |
2.97 | 17893378 17440819 17952589 17049068 15572757 17595753 16912660 16837676 15758505 15775269 17261762 17242785 |
| MESH:D001943 |
Breast Neoplasms |
|
Tetrachlorodibenzodioxin |
2.97 | 20435547 |
| MESH:D002181 |
Candidiasis, Vulvovaginal |
|
Estradiol |
4.48 | 16111702 |
| MESH:D002277 |
Carcinoma |
|
Tetrachlorodibenzodioxin |
2.80 | 16835633 |
| MESH:D006528 |
Carcinoma, Hepatocellular |
|
Acetaminophen |
4.54 | 3084413 |
| MESH:D006528 |
Carcinoma, Hepatocellular |
|
Aflatoxin B1 |
4.54 | 21507988 12619106 12907637 |
| MESH:D006528 |
Carcinoma, Hepatocellular |
|
Estradiol |
4.54 | 16924424 |
| MESH:D002295 |
Carcinoma, Transitional Cell |
|
Raloxifene |
4.08 | 17572228 |
| MESH:D006332 |
Cardiomegaly |
|
Tetrachlorodibenzodioxin |
2.37 | 18670907 18850075 16120746 |
| MESH:D002318 |
Cardiovascular Diseases |
|
Raloxifene |
3.45 | 15775269 |
| MESH:D002386 |
Cataract |
|
Acetaminophen |
2.58 | 10977129 |
| MESH:D002471 |
Cell Transformation, Neoplastic |
|
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
11.15 | 20889678 |
| MESH:D002471 |
Cell Transformation, Neoplastic |
|
Cyclosporine |
11.15 | 12371664 |
| MESH:D002471 |
Cell Transformation, Neoplastic |
|
Estradiol |
11.15 | 18566989 |
| MESH:D018281 |
Cholangiocarcinoma |
|
Tetrachlorodibenzodioxin |
3.16 | 16835633 |
| MESH:D002779 |
Cholestasis |
|
Cyclosporine |
13.36 | 19486331 |
| MESH:D002779 |
Cholestasis |
|
Ethinyl Estradiol |
13.36 | 17110522 15861022 16105132 11677210 17681005 16919318 17333356 |
| MESH:D002779 |
Cholestasis |
|
pirinixic acid |
13.36 | 19176532 |
| MESH:D002972 |
Cleft Palate |
|
Tetrachlorodibenzodioxin |
2.10 | 16354765 12621046 8697196 15340226 15668235 |
| MESH:D003072 |
Cognition Disorders |
|
Raloxifene |
4.63 | 15800139 |
| MESH:D003092 |
Colitis |
|
Trinitrobenzenesulfonic Acid |
4.56 | 16782535 17991707 18200517 17936198 16804969 16867261 16474422 18023891 11698051 |
| MESH:D003093 |
Colitis, Ulcerative |
|
Trinitrobenzenesulfonic Acid |
3.44 | 17276891 |
| MESH:D000013 |
Congenital Abnormalities |
|
Tetrachlorodibenzodioxin |
3.06 | 17141729 14669216 |
| MESH:D019465 |
Craniofacial Abnormalities |
marker/mechanism |
|
| 18925670 |
| MESH:D019465 |
Craniofacial Abnormalities |
|
Methotrexate |
2.75 | 9562676 12039119 |
| MESH:D019465 |
Craniofacial Abnormalities |
|
Tetrachlorodibenzodioxin |
2.75 | 15322242 20055451 10048152 |
| MESH:D003550 |
Cystic Fibrosis |
|
Methotrexate |
4.24 | 19747007 |
| MESH:D003865 |
Depressive Disorder, Major |
|
Raloxifene |
4.16 | 17474826 |
| MESH:D003876 |
Dermatitis, Atopic |
|
pirinixic acid |
2.43 | 18249437 |
| MESH:D003882 |
Dermatomyositis |
|
Methotrexate |
5.13 | 20191521 |
| MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Tetrachlorodibenzodioxin |
1.67 | 17107852 |
| MESH:D003928 |
Diabetic Nephropathies |
|
Estradiol |
9.02 | 19279558 |
| MESH:D003928 |
Diabetic Nephropathies |
|
Raloxifene |
9.02 | 17308373 15920148 17451421 |
| MESH:D003929 |
Diabetic Neuropathies |
|
Progesterone |
4.51 | 17187935 |
| MESH:C536170 |
Diastrophic dysplasia |
marker/mechanism |
|
| |
| MESH:D056486 |
Drug-Induced Liver Injury |
|
Acetaminophen |
3.56 | 11529661 19370779 14550746 19416960 11743745 12392966 18713872 16227642 10915739 16393943 11287661 11834606 12540782 19739265 17906064 16177239 2444490 16109766 11739529 10774834 10663392 14986274 12153990 17562736 19923254 12594235 12705907 12958197 15619225 16081117 18071297 19085960 16485898 15968718 19164858 16781746 14725611 11421492 17522070 11461765 19420014 |
| MESH:D056486 |
Drug-Induced Liver Injury |
|
Tetrachlorodibenzodioxin |
3.56 | 20420201 |
| MESH:D056487 |
Drug-Induced Liver Injury, Chronic |
|
Acetaminophen |
4.13 | 19426721 |
| MESH:D004362 |
Drug Toxicity |
|
Tetrachlorodibenzodioxin |
2.76 | 11462148 |
| MESH:D004427 |
Ear Diseases |
marker/mechanism |
|
| 18925670 |
| MESH:D004487 |
Edema |
|
pirinixic acid |
11.46 | 12083418 |
| MESH:D004487 |
Edema |
|
Raloxifene |
11.46 | 15860553 |
| MESH:D004487 |
Edema |
|
Tetrachlorodibenzodioxin |
11.46 | 12711302 11000095 |
| MESH:D004489 |
Edema, Cardiac |
|
Tetrachlorodibenzodioxin |
3.93 | 18230668 16714409 15322242 |
| MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Ethinyl Estradiol |
15.45 | 12538720 |
| MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Progesterone |
15.45 | 17692515 |
| MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Raloxifene |
15.45 | 15845917 |
| MESH:D016889 |
Endometrial Neoplasms |
|
4-hydroxytamoxifen |
7.79 | 19148513 |
| MESH:D016889 |
Endometrial Neoplasms |
|
Estradiol |
7.79 | 11473722 18566989 19148513 |
| MESH:D004715 |
Endometriosis |
|
Progesterone |
8.94 | 16134523 |
| MESH:D004715 |
Endometriosis |
|
Tetrachlorodibenzodioxin |
8.94 | 10568697 9294722 |
| MESH:C535504 |
Epiphyseal dysplasia, multiple, 4 |
marker/mechanism |
|
| |
| MESH:D004938 |
Esophageal Neoplasms |
|
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
2.07 | 20426865 |
| MESH:D005124 |
Eye Abnormalities |
|
Tetrachlorodibenzodioxin |
3.01 | 11564622 |
| MESH:D005234 |
Fatty Liver |
|
Cyclosporine |
18.81 | 19224547 |
| MESH:D005234 |
Fatty Liver |
|
Ethinyl Estradiol |
18.81 | 15345470 |
| MESH:D005234 |
Fatty Liver |
|
pirinixic acid |
18.81 | 19236843 20131406 |
| MESH:D005234 |
Fatty Liver |
|
Raloxifene |
18.81 | 17473493 |
| MESH:D005313 |
Fetal Death |
|
Tetrachlorodibenzodioxin |
3.47 | 11858732 |
| MESH:D005355 |
Fibrosis |
|
Cyclosporine |
14.92 | 12639820 12168785 |
| MESH:D005355 |
Fibrosis |
|
Tetrachlorodibenzodioxin |
14.92 | 20067830 |
| MESH:D005355 |
Fibrosis |
|
Trinitrobenzenesulfonic Acid |
14.92 | 17994277 |
| MESH:D005756 |
Gastritis |
|
Acetaminophen |
3.71 | 16983495 |
| MESH:D005885 |
Gingival Hyperplasia |
|
Cyclosporine |
4.24 | 8708960 |
| MESH:D006058 |
Gonadal Disorders |
|
Tetrachlorodibenzodioxin |
4.62 | 10696789 |
| MESH:D006086 |
Graft vs Host Disease |
|
Methotrexate |
5.16 | 16518429 |
| MESH:D006330 |
Heart Defects, Congenital |
|
Tetrachlorodibenzodioxin |
2.33 | 11294989 10048152 |
| MESH:D006331 |
Heart Diseases |
|
Raloxifene |
3.54 | 11110106 |
| MESH:D006333 |
Heart Failure |
|
pirinixic acid |
2.54 | 20558911 |
| MESH:D006457 |
Hemoglobinuria, Paroxysmal |
|
Cyclosporine |
4.44 | 15720958 |
| MESH:D006470 |
Hemorrhage |
|
Tetrachlorodibenzodioxin |
3.34 | 11000095 |
| MESH:D006529 |
Hepatomegaly |
|
pirinixic acid |
8.31 | 16221962 18467677 19176532 19772884 |
| MESH:D006529 |
Hepatomegaly |
|
Tetrachlorodibenzodioxin |
8.31 | 15340226 16120746 12621046 |
| MESH:D006558 |
Herpes Genitalis |
|
Estradiol |
5.06 | 15709030 |
| MESH:D019584 |
Hot Flashes |
|
Estradiol |
3.78 | 17088409 |
| MESH:D006869 |
Hydronephrosis |
|
Tetrachlorodibenzodioxin |
4.08 | 8697196 18606429 16959395 15340226 16354765 |
| MESH:D006930 |
Hyperalgesia |
|
Acetaminophen |
2.70 | 16870215 |
| MESH:D006943 |
Hyperglycemia |
|
pirinixic acid |
3.19 | 20558911 |
| MESH:D006973 |
Hypertension |
|
Cyclosporine |
8.59 | 10903974 |
| MESH:D006973 |
Hypertension |
|
Raloxifene |
8.59 | 17577099 15787275 |
| MESH:D006973 |
Hypertension |
|
Tetrachlorodibenzodioxin |
8.59 | 18850075 18670907 |
| MESH:D007021 |
Hypospadias |
|
Ethinyl Estradiol |
3.82 | 16569931 16945680 |
| MESH:D020244 |
Infarction, Middle Cerebral Artery |
|
Progesterone |
4.41 | 15869954 |
| MESH:D007247 |
Infertility, Female |
|
Ethinyl Estradiol |
3.47 | 12013081 |
| MESH:D007248 |
Infertility, Male |
|
Ethinyl Estradiol |
6.93 | 17937319 |
| MESH:D007248 |
Infertility, Male |
|
fulvestrant |
6.93 | 11514358 |
| MESH:D007249 |
Inflammation |
|
Progesterone |
4.98 | 15869954 |
| MESH:D007249 |
Inflammation |
|
Tetrachlorodibenzodioxin |
4.98 | 12200463 12878042 |
| MESH:D015212 |
Inflammatory Bowel Diseases |
|
Trinitrobenzenesulfonic Acid |
3.58 | 18200517 |
| MESH:D007333 |
Insulin Resistance |
|
Estradiol |
7.20 | 16627594 16393666 |
| MESH:D007333 |
Insulin Resistance |
|
pirinixic acid |
7.20 | 16306350 |
| MESH:D007410 |
Intestinal Diseases |
|
Trinitrobenzenesulfonic Acid |
4.62 | 17994277 |
| MESH:D007569 |
Jaw Abnormalities |
|
Tetrachlorodibenzodioxin |
3.34 | 16580747 |
| MESH:D007638 |
Keratoconjunctivitis Sicca |
|
Cyclosporine |
4.47 | 15604871 |
| MESH:D007674 |
Kidney Diseases |
|
Acetaminophen |
9.98 | 15629191 12587719 |
| MESH:D007674 |
Kidney Diseases |
|
Cyclosporine |
9.98 | 8314463 10903974 18776723 |
| MESH:D007674 |
Kidney Diseases |
|
Estradiol |
9.98 | 15618244 |
| MESH:D007680 |
Kidney Neoplasms |
|
Cyclosporine |
7.28 | 12371664 |
| MESH:D007680 |
Kidney Neoplasms |
|
Estradiol |
7.28 | 15610895 |
| MESH:D007738 |
Kyphosis |
marker/mechanism |
|
| 18925670 |
| MESH:D007805 |
Language Development Disorders |
|
Methotrexate |
5.11 | 9562676 |
| MESH:D007889 |
Leiomyoma |
|
Raloxifene |
4.50 | 16973256 |
| MESH:D008103 |
Liver Cirrhosis |
|
Methotrexate |
3.70 | 14986274 |
| MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Estradiol |
3.38 | 14659978 14716833 |
| MESH:D008106 |
Liver Cirrhosis, Experimental |
|
pirinixic acid |
3.38 | 15474484 |
| MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tetrachlorodibenzodioxin |
3.38 | 12878042 |
| MESH:D008107 |
Liver Diseases |
|
Acetaminophen |
1.63 | 19014921 16611625 12969438 12587719 19460945 11587558 19784758 16610002 |
| MESH:D017114 |
Liver Failure, Acute |
|
Acetaminophen |
3.24 | 17185352 16871587 |
| MESH:D008113 |
Liver Neoplasms |
|
Aflatoxin B1 |
7.36 | 18177683 9163691 15890375 2125692 |
| MESH:D008113 |
Liver Neoplasms |
|
pirinixic acid |
7.36 | 20007298 16377806 15890375 |
| MESH:D008113 |
Liver Neoplasms |
|
Tetrachlorodibenzodioxin |
7.36 | 16984957 |
| MESH:D008114 |
Liver Neoplasms, Experimental |
|
Aflatoxin B1 |
5.81 | 8603461 |
| MESH:D008114 |
Liver Neoplasms, Experimental |
|
Tetrachlorodibenzodioxin |
5.81 | 12151625 |
| MESH:D017563 |
Lung Diseases, Interstitial |
|
Methotrexate |
5.05 | 18516814 |
| MESH:D008175 |
Lung Neoplasms |
|
Aflatoxin B1 |
2.30 | 14755239 |
| MESH:D008175 |
Lung Neoplasms |
|
Tetrachlorodibenzodioxin |
2.30 | 11884234 19555203 |
| MESH:D008223 |
Lymphoma |
|
Methotrexate |
3.95 | 17352296 |
| MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Estradiol |
6.06 | 16891317 11807958 17203775 11408345 |
| MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Progesterone |
6.06 | 17203775 11408345 |
| MESH:D020149 |
Manganese Poisoning |
|
Estradiol |
4.51 | 19453300 |
| MESH:D008546 |
Melanoma, Experimental |
|
Acetaminophen |
3.58 | 19513568 |
| MESH:D008664 |
Metal Metabolism, Inborn Errors |
|
Cyclosporine |
4.82 | 16801185 |
| MESH:D018200 |
Mixed Tumor, Mullerian |
|
Raloxifene |
5.58 | 15863610 |
| MESH:D052016 |
Mucositis |
|
Methotrexate |
5.30 | 17488658 |
| MESH:D009101 |
Multiple Myeloma |
|
Raloxifene |
3.44 | 16497877 |
| MESH:D009135 |
Muscular Diseases |
|
pirinixic acid |
3.52 | 16239165 |
| MESH:D009203 |
Myocardial Infarction |
|
pirinixic acid |
2.14 | 19151258 |
| MESH:D017202 |
Myocardial Ischemia |
|
Tetrachlorodibenzodioxin |
3.02 | 12213967 |
| MESH:D015428 |
Myocardial Reperfusion Injury |
|
Estradiol |
8.26 | 16810080 |
| MESH:D015428 |
Myocardial Reperfusion Injury |
|
pirinixic acid |
8.26 | 16411023 |
| MESH:D009232 |
Myxoma |
|
Raloxifene |
5.58 | 16343187 |
| MESH:D009369 |
Neoplasms |
|
pirinixic acid |
1.95 | 17405874 |
| MESH:D009389 |
Neovascularization, Pathologic |
|
Estradiol |
3.75 | 17289903 |
| MESH:D009402 |
Nephrosis, Lipoid |
|
Cyclosporine |
4.47 | 17954296 |
| MESH:D009404 |
Nephrotic Syndrome |
|
Cyclosporine |
3.29 | 19348381 18481113 |
| MESH:D009421 |
Nervous System Malformations |
|
Estradiol |
9.50 | 11399458 16427766 |
| MESH:D009421 |
Nervous System Malformations |
|
Tetrachlorodibenzodioxin |
9.50 | 14600291 |
| MESH:D019636 |
Neurodegenerative Diseases |
|
Acetaminophen |
2.87 | 18514411 |
| MESH:D009765 |
Obesity |
|
pirinixic acid |
1.81 | 20558911 |
| MESH:D010024 |
Osteoporosis |
|
Raloxifene |
3.39 | 15775268 19059307 17882678 |
| MESH:D015663 |
Osteoporosis, Postmenopausal |
|
Raloxifene |
4.23 | 15758505 17893378 17823083 15579764 |
| MESH:D010051 |
Ovarian Neoplasms |
|
Estradiol |
4.87 | 19401270 |
| MESH:D010051 |
Ovarian Neoplasms |
|
Progesterone |
4.87 | 16525653 17393432 |
| MESH:D010146 |
Pain |
|
Acetaminophen |
2.39 | 16870215 |
| MESH:D010195 |
Pancreatitis |
|
Trinitrobenzenesulfonic Acid |
4.21 | 17698068 |
| MESH:D016584 |
Panic Disorder |
|
Ethinyl Estradiol |
3.69 | 11578682 |
| MESH:D010382 |
Peliosis Hepatis |
|
Tetrachlorodibenzodioxin |
4.28 | 12520081 |
| MESH:D017119 |
Porphyria Cutanea Tarda |
|
Tetrachlorodibenzodioxin |
3.57 | 18163543 |
| MESH:D011230 |
Precancerous Conditions |
|
Cyclosporine |
3.22 | 12371664 |
| MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Tetrachlorodibenzodioxin |
3.21 | 11896295 11222880 11118676 11399792 |
| MESH:D019048 |
Prostatic Intraepithelial Neoplasia |
|
Estradiol |
3.89 | 20887781 |
| MESH:D011471 |
Prostatic Neoplasms |
|
Estradiol |
3.34 | 16740699 |
| MESH:D011471 |
Prostatic Neoplasms |
|
Raloxifene |
3.34 | 16536755 15731164 16220300 |
| MESH:D011537 |
Pruritus |
|
Ethinyl Estradiol |
3.33 | 15861022 16919318 |
| MESH:D011565 |
Psoriasis |
|
Cyclosporine |
5.91 | 16882103 |
| MESH:D011565 |
Psoriasis |
|
Methotrexate |
5.91 | 17410198 |
| MESH:D011693 |
Purpura |
|
Raloxifene |
5.58 | 15770314 |
| MESH:D051437 |
Renal Insufficiency |
|
Methotrexate |
4.72 | 17352296 |
| MESH:D015427 |
Reperfusion Injury |
|
pirinixic acid |
2.39 | 19058328 |
| MESH:D015619 |
Respiratory System Abnormalities |
|
Tetrachlorodibenzodioxin |
3.85 | 18990726 |
| MESH:D012468 |
Salivary Gland Neoplasms |
|
Progesterone |
2.86 | 18045962 |
| MESH:D012878 |
Skin Neoplasms |
|
Tetrachlorodibenzodioxin |
2.04 | 16192470 |
| MESH:D013088 |
Spermatocele |
|
Ethinyl Estradiol |
3.97 | 16709447 |
| MESH:D013119 |
Spinal Cord Injuries |
|
Progesterone |
4.30 | 15862959 16503802 |
| MESH:D020521 |
Stroke |
|
Raloxifene |
3.82 | 16837676 |
| MESH:D013576 |
Syndactyly |
|
Methotrexate |
5.04 | 9562676 |
| MESH:D019851 |
Thrombophilia |
|
Ethinyl Estradiol |
3.63 | 11994571 |
| MESH:D013927 |
Thrombosis |
|
Ethinyl Estradiol |
3.15 | 15669648 |
| MESH:D013959 |
Thyroid Diseases |
|
Tetrachlorodibenzodioxin |
3.93 | 12697716 |
| MESH:D013978 |
Tibial Fractures |
|
Estradiol |
13.82 | 19048282 |
| MESH:D013978 |
Tibial Fractures |
|
Raloxifene |
13.82 | 19048282 |
| MESH:D001749 |
Urinary Bladder Neoplasms |
|
Raloxifene |
2.81 | 17572228 |
| MESH:D014581 |
Urticaria |
|
Acetaminophen |
2.98 | 10982225 |
| MESH:D014594 |
Uterine Neoplasms |
|
Ethinyl Estradiol |
3.31 | 14692618 |
| MESH:D014605 |
Uveitis |
|
Cyclosporine |
4.01 | 1336536 |
| MESH:D054079 |
Vascular Malformations |
|
Tetrachlorodibenzodioxin |
4.62 | 12125929 |
| MESH:D054556 |
Venous Thromboembolism |
|
Raloxifene |
5.24 | 16837676 |
| MESH:D020246 |
Venous Thrombosis |
|
Ethinyl Estradiol |
3.54 | 14671159 15869587 |
| MESH:D014846 |
Vulvar Neoplasms |
|
Raloxifene |
5.58 | 16343187 |
| MESH:D019282 |
Wasting Syndrome |
|
Tetrachlorodibenzodioxin |
4.28 | 15886252 |
| MESH:D014985 |
Xerophthalmia |
|
Cyclosporine |
4.47 | 17120751 |